BG-forum2

Despite pandemic conditions, compliance monitoring of partners and vendors is possible. QFINITY has supported the adaptation of a pharmacovigilance audit program from an on-site to a remote audit model at a medium-sized pharmaceutical company. Due to travel restrictions, QFINITY is supporting the same manufacturer in conducting remote audits to monitor pharmacovigilance agreements with partners worldwide. The switch from “on-site” audits to remote audits was made after a thorough risk assessment in response to the Covid-19 pandemic.